Human Investing LLC Novo Nordisk A S Transaction History

Human Investing LLC

$550 Million
Q3 2024

A detailed history of Human Investing LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Human Investing LLC holds 22,873 shares of NVO stock, worth $2.37 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares

22,873

Previous 23,290 1.79%

Holding current value

$2.37 Million

Previous $3.32 Million 18.08%

% of portfolio

0.49%

Previous 0.65%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$119.07 - $145.42 $49,652 - $60,640	-417 Reduced 1.79%	22,873 $2.72 Million
Q1 2024 Apr 25, 2024	SELL	$102.11 - $135.92 $21,034 - $27,999	-206 Reduced 0.88%	23,290 $2.99 Million
Q4 2023 Feb 12, 2024	SELL	$87.78 - $105.45 $149,401 - $179,475	-1,702 Reduced 6.75%	23,496 $2.43 Million
Q3 2023 Nov 09, 2023	BUY	$90.94 - $199.54 $1.13 Million - $2.48 Million	12,432 Added 97.38%	25,198 $2.29 Million
Q2 2023 Aug 07, 2023	SELL	$155.98 - $172.65 $57,088 - $63,189	-366 Reduced 2.79%	12,766 $2.07 Million
Q1 2023 May 10, 2023	SELL	$132.34 - $159.14 $89,991 - $108,215	-680 Reduced 4.92%	13,132 $2.09 Million
Q4 2022 Jan 27, 2023	SELL	$102.55 - $135.33 $179,462 - $236,827	-1,750 Reduced 11.25%	13,812 $0
Q3 2022 Oct 31, 2022	SELL	$95.28 - $116.93 $19,437 - $23,853	-204 Reduced 1.29%	15,562 $1.55 Million
Q2 2022 Jul 27, 2022	SELL	$103.24 - $121.81 $19,409 - $22,900	-188 Reduced 1.18%	15,766 $1.76 Million
Q1 2022 May 05, 2022	SELL	$93.1 - $112.54 $581,875 - $703,375	-6,250 Reduced 28.15%	15,954 $1.77 Million
Q4 2021 Feb 10, 2022	SELL	$95.88 - $117.08 $558,980 - $682,576	-5,830 Reduced 20.8%	22,204 $2.49 Million
Q3 2021 Nov 04, 2021	SELL	$84.42 - $106.62 $139,630 - $176,349	-1,654 Reduced 5.57%	28,034 $2.69 Million
Q2 2021 Aug 02, 2021	SELL	$67.66 - $84.76 $21,718 - $27,207	-321 Reduced 1.07%	29,688 $2.49 Million
Q1 2021 May 05, 2021	SELL	$67.06 - $75.82 $209,696 - $237,089	-3,127 Reduced 9.44%	30,009 $2.02 Million
Q4 2020 Feb 04, 2021	SELL	$63.89 - $73.8 $477,322 - $551,359	-7,471 Reduced 18.4%	33,136 $2.32 Million
Q3 2020 Oct 27, 2020	SELL	$63.69 - $70.22 $233,805 - $257,777	-3,671 Reduced 8.29%	40,607 $2.82 Million
Q2 2020 Jul 22, 2020	SELL	$58.54 - $67.94 $723,027 - $839,126	-12,351 Reduced 21.81%	44,278 $2.9 Million
Q1 2020 Apr 22, 2020	SELL	$49.46 - $64.78 $289,439 - $379,092	-5,852 Reduced 9.37%	56,629 $3.41 Million
Q4 2019 Feb 07, 2020	BUY	$49.86 - $58.26 $897 - $1,048	18 Added 0.03%	62,481 $3.62 Million
Q3 2019 Nov 07, 2019	SELL	$47.54 - $53.43 $47,635 - $53,536	-1,002 Reduced 1.58%	62,463 $3.23 Million
Q2 2019 Aug 16, 2019	SELL	$46.79 - $52.47 $139,527 - $156,465	-2,982 Reduced 4.49%	63,465 $3.24 Million
Q1 2019 May 14, 2019	SELL	$46.36 - $52.63 $80,110 - $90,944	-1,728 Reduced 2.53%	66,447 $3.48 Million
Q4 2018 Feb 14, 2019	BUY	$41.54 - $47.25 $2.83 Million - $3.22 Million	68,175 New	68,175 $3.14 Million

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $233B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Human Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Human Investing LLC with notifications on news.

Account

Human Investing LLC Novo Nordisk A S Transaction History